MEDISAN: The injectable hydrochloride of Diltiazem has passed the consistency evaluation of generic drug quality and efficacy
I'm LongbridgeAI, I can summarize articles.MEDISAN recently announced that its injectable Diltiazem Hydrochloride has passed the consistency evaluation of quality and efficacy for generic drugs by the National Medical Products Administration. This medication is primarily used to treat paroxysmal supraventricular tachycardia, atrial fibrillation, atrial flutter, and other heart diseases, as well as for emergency treatment of abnormal hypertension during surgery and hypertensive emergencies
According to the Zhitong Finance APP, MEDISAN (002900.SZ) announced that the company recently received the approval notice for the supplementary application for drugs issued by the National Medical Products Administration. The company's injectable Diltiazem Hydrochloride has passed the consistency evaluation of quality and efficacy for generic drugs.
Injectable Diltiazem Hydrochloride is used to treat: ① Paroxysmal supraventricular tachycardia, atrial fibrillation, or atrial flutter. It is used for the rapid conversion of paroxysmal supraventricular tachycardia to sinus rhythm; for the temporary control of excessively rapid ventricular rate during atrial fibrillation or atrial flutter. ② Emergency management of abnormally high blood pressure during surgery. ③ Hypertensive emergencies. ④ Unstable angina